BSE Live
Dec 18, 16:01Prev. Close
1272.00
Open Price
1271.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 18, 15:58Prev. Close
1272.00
Open Price
1277.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1280.00 (338)
| Key Financial Ratios of Dr Reddys Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 122.22 | 117.53 | 57.08 | 77.53 | 124.93 | |
| Diluted EPS (Rs.) | 121.99 | 117.33 | 56.96 | 77.37 | 124.54 | |
| Cash EPS (Rs.) | 188.51 | 183.19 | 119.86 | 137.74 | 178.58 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 938.56 | 844.80 | 757.33 | 739.57 | 736.80 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 938.56 | 844.80 | 757.33 | 739.57 | 736.80 | |
| Revenue from Operations/Share (Rs.) | 1,053.97 | 930.61 | 860.30 | 856.22 | 912.56 | |
| PBDIT/Share (Rs.) | 185.98 | 211.79 | 150.99 | 159.45 | 227.45 | |
| PBIT/Share (Rs.) | 116.00 | 143.43 | 86.10 | 97.53 | 172.42 | |
| PBT/Share (Rs.) | 110.08 | 138.07 | 81.35 | 93.71 | 167.57 | |
| Net Profit/Share (Rs.) | 118.53 | 114.83 | 54.96 | 75.83 | 123.55 | |
| NP After MI And SOA / Share (Rs.) | 121.90 | 117.47 | 57.04 | 77.93 | 124.89 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 17.64 | 22.75 | 17.55 | 18.62 | 24.92 | |
| PBIT Margin (%) | 11.00 | 15.41 | 10.00 | 11.39 | 18.89 | |
| PBT Margin (%) | 10.44 | 14.83 | 9.45 | 10.94 | 18.36 | |
| Net Profit Margin (%) | 11.24 | 12.33 | 6.38 | 8.85 | 13.53 | |
| NP After MI And SOA Margin (%) | 11.56 | 12.62 | 6.62 | 9.10 | 13.68 | |
| Return on Networth/Equity (%) | 12.98 | 13.90 | 7.53 | 10.53 | 16.95 | |
| Return on Capital Employed (%) | 12.04 | 14.37 | 9.13 | 12.07 | 15.17 | |
| Return on Assets (%) | 8.72 | 8.67 | 4.19 | 5.92 | 10.45 | |
| Total Debt/Equity (X) | 0.11 | 0.24 | 0.40 | 0.40 | 0.27 | |
| Asset Turnover Ratio (%) | 75.42 | 68.76 | 63.34 | 65.07 | 76.37 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.75 | 1.88 | 1.52 | 1.15 | 1.86 | |
| Quick Ratio (X) | 1.26 | 1.31 | 1.10 | 0.81 | 1.46 | |
| Inventory Turnover Ratio (X) | 5.00 | 4.60 | 4.91 | 4.98 | 6.09 | |
| Dividend Payout Ratio (NP) (%) | 19.32 | 17.02 | 42.16 | 26.23 | 19.27 | |
| Dividend Payout Ratio (CP) (%) | 12.27 | 10.76 | 19.72 | 14.62 | 13.37 | |
| Earnings Retention Ratio (%) | 80.68 | 82.98 | 57.84 | 73.77 | 80.73 | |
| Cash Earnings Retention Ratio (%) | 87.73 | 89.24 | 80.28 | 85.38 | 86.63 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 19.61 | 26.78 | 18.14 | 25.51 | 35.61 | |
| Interest Coverage Ratios (Post Tax) (%) | 19.61 | 26.78 | 18.14 | 25.51 | 35.61 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 53,384.50 | 49,240.59 | 39,369.97 | 48,167.85 | 54,623.59 | |
| EV/Net Operating Revenue (X) | 3.05 | 3.19 | 2.76 | 3.39 | 3.51 | |
| EV/EBITDA (X) | 17.27 | 14.01 | 15.71 | 18.22 | 14.08 | |
| MarketCap/Net Operating Revenue (X) | 2.96 | 2.98 | 2.42 | 3.07 | 3.33 | |
| Retention Ratios (%) | 80.67 | 82.97 | 57.83 | 73.76 | 80.72 | |
| Price/BV (X) | 3.32 | 3.28 | 2.75 | 3.56 | 4.12 | |
| Price/Net Operating Revenue | 2.96 | 2.98 | 2.42 | 3.07 | 3.33 | |
| Earnings Yield | 0.04 | 0.04 | 0.03 | 0.03 | 0.04 |
15.12.2025
12.12.2025
25.11.2025
11.11.2025
28.10.2025
Dr Reddys Labs Consolidated September 2025 Net Sales at Rs 8,828.30 crore, up 9.83% Y-o-Y
28.10.2025
Dr Reddys Labs Standalone September 2025 Net Sales at Rs 4,618.60 crore, down 31.03% Y-o-Y
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
24.07.2025
Dr Reddys Labs Standalone June 2025 Net Sales at Rs 7,809.50 crore, up 33.7% Y-o-Y
22.01.2025
Dr Reddy's Labs Q3 Preview: Lower Revlimid contribution, subdued US sales to dent earnings growth
12.07.2023
Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang
24.01.2023
Dr Reddy’s Q3 Preview | Sharp drop in net profit likely on slump in US revenues
27.10.2022
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz